Identification of novel protein/DNA interactions within the promoter of the bone-related transcription factor Runx2/Cbfa1

被引:27
作者
Drissi, H [1 ]
Pouliot, A [1 ]
Stein, JL [1 ]
van Wijnen, AJ [1 ]
Stein, GS [1 ]
Lian, JB [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA
关键词
Runx2/Cbfa1; promoter; osteoblast; transcription; gene expression;
D O I
10.1002/jcb.10238
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The runt homology transcription factor Runx2/Cbfa1 is essential for bone development and osteoblast differentiation. Regulatory mechanisms that govern Runx2 transcription in osteoblasts define the osteogenic pathways that control skeletal development. In this Study, we systematically examined transcription factor binding within the upstream Runx2 P1 promoter, which regulates expression of the bone-related Runx2 factor. We identified two novel protein/DNA interactions that are mediated by sequence specific factors, based on cross-corn petition experiments, point mutations, and gel-shift immunoassays. One complex recognizes a non-canonical Runx2 site, whereas the other factor binds to a palindromic sequence. Site-directed mutagenesis of the novel Runx2 motif (5'TCCCAC3') within the 0.6 kb rat Runx2 promoter reduces transcription by 2-fold, indicating that this site supports enhancement of Runx2 promoter activity. Mutation of the palindromic motif (5'AGTACT3') results in a 2-3-fold activation of the Runx2 promoter, demonstrating that the wild type sequence contributes to transcriptional repression. These studies, together with our previous findings of auto-suppression of the Runx2 promoter and negative regulation by 1,25(OH)(2) Vitamin D3, suggest that physiological control of Runx2 gene expression is mediated by a series of intricate regulatory mechanisms. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:403 / 412
页数:10
相关论文
共 39 条
[31]   Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development [J].
Otto, F ;
Thornell, AP ;
Crompton, T ;
Denzel, A ;
Gilmour, KC ;
Rosewell, IR ;
Stamp, GWH ;
Beddington, RSP ;
Mundlos, S ;
Olsen, BR ;
Selby, PB ;
Owen, MJ .
CELL, 1997, 89 (05) :765-771
[32]  
Prince M, 2001, J CELL BIOCHEM, V80, P424, DOI 10.1002/1097-4644(20010301)80:3<424::AID-JCB160>3.0.CO
[33]  
2-6
[34]   Antagonistic effects of transforming growth factor-beta on vitamin D-3, enhancement of osteocalcin and osteopontin transcription: Reduced interactions of vitamin D receptor retinoid X receptor complexes with vitamin D response elements [J].
Staal, A ;
VanWijnen, AJ ;
Desai, RK ;
Pols, HAP ;
Birkenhager, JC ;
Deluca, HF ;
Denhardt, DT ;
Stein, JL ;
VanLeeuwen, JPTM ;
Stein, GS ;
Lian, JB .
ENDOCRINOLOGY, 1996, 137 (05) :2001-2011
[35]   Distinct conformations of vitamin D receptor retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes [J].
Staal, A ;
vanWijnen, AJ ;
Birkenhager, JC ;
Pols, HAP ;
Prahl, J ;
DeLuca, H ;
Gaub, MP ;
Lian, JB ;
Stein, GS ;
vanLeeuwen, JPTM ;
Stein, JL .
MOLECULAR ENDOCRINOLOGY, 1996, 10 (11) :1444-1456
[36]   Expression of the PEBP2αA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells [J].
Tsuji, K ;
Ito, Y ;
Noda, M .
BONE, 1998, 22 (02) :87-92
[37]   RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 STIMULATES OSTEOBLASTIC MATURATION AND INHIBITS MYOGENIC DIFFERENTIATION INVITRO [J].
YAMAGUCHI, A ;
KATAGIRI, T ;
IKEDA, T ;
WOZNEY, JM ;
ROSEN, V ;
WANG, EA ;
KAHN, AJ ;
SUDA, T ;
YOSHIKI, S .
JOURNAL OF CELL BIOLOGY, 1991, 113 (03) :681-687
[38]   CLONAL OSTEOGENIC CELL-LINES EXPRESS MYOGENIC AND ADIPOCYTIC DEVELOPMENTAL POTENTIAL [J].
YAMAGUCHI, A ;
KAHN, AJ .
CALCIFIED TISSUE INTERNATIONAL, 1991, 49 (03) :221-225
[39]   Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1 [J].
Yamaguchi, A ;
Komori, T ;
Suda, T .
ENDOCRINE REVIEWS, 2000, 21 (04) :393-411